Autolus Therapeutics Ownership | Who Owns Autolus Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Autolus Therapeutics Ownership Summary

Autolus Therapeutics is owned by 1.33% institutional investors, 18.08% insiders, and 80.59% retail investors. Mak capital one is the largest institutional shareholder, holding 12.63% of AUTL shares. Syncona Ord is the top mutual fund, with 11.55% of its assets in Autolus Therapeutics shares.

AUTL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Autolus Therapeutics	1.33%	18.08%	80.59%
Sector	Healthcare Stocks	35.38%	11.35%	53.27%
Industry	Biotech Stocks	33.91%	11.39%	54.70%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Mak capital one	33.62M	12.63%	$46.40M
Blackstone	20.49M	7.70%	$28.27M
Syncona portfolio	16.64M	6.25%	$22.96M
Armistice capital	15.80M	5.94%	$21.80M
Tfg asset management gp	9.50M	3.57%	$13.11M
Schroder investment management group	9.49M	3.57%	$12.05M
Blackrock	4.44M	2.00%	$15.44M
Frazier life sciences management	4.45M	1.67%	$6.14M
Bnp paribas asset management	3.36M	1.26%	$4.64M
Axa investment managers	3.36M	1.26%	$5.48M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Syncona portfolio	16.64M	89.33%	$22.96M
Mak capital one	33.62M	6.84%	$46.40M
Tfg asset management gp	9.50M	2.55%	$13.11M
Armistice capital	15.80M	0.39%	$21.80M
Laurion capital management lp	3.32M	0.20%	$4.58M
Nano cap new millennium growth fund l p	150.00K	0.19%	$207.00K
Frazier life sciences management	4.45M	0.16%	$6.14M
Edentree asset management	300.00K	0.12%	$414.00K
Blackstone	20.49M	0.11%	$28.27M
Privium fund management b.v.	363.43K	0.10%	$501.53K

Top Buyers

Holder	Shares	% Assets	Change
Mak capital one	33.62M	6.84%	3.62M
Axa investment managers	3.36M	0.01%	3.36M
Balyasny asset management	971.69K	0.00%	971.69K
Marex group	542.86K	0.00%	542.86K
Ubs group	1.31M	0.00%	428.68K

Top Sellers

Holder	Shares	% Assets	Change
Wellington management group llp	-	-	-27.15M
Avoro capital advisors	-	-	-9.91M
Fmr	-	-	-7.11M
Cormorant asset management, lp	-	-	-6.62M
Paradigm biocapital advisors lp	-	-	-6.43M

New Positions

Holder	Shares	% Assets	Change	Value
Axa investment managers	3.36M	0.01%	3.36M	$5.48M
Balyasny asset management	971.69K	0.00%	971.69K	$1.34M
Marex group	542.86K	0.00%	542.86K	$749.14K
Graham capital management	147.88K	0.00%	147.88K	$241.04K
Public employees retirement system of ohio	132.69K	0.00%	132.69K	$216.28K

Sold Out

Holder	Change
Principal securities	-37.00
Us bancorp \de\	-64.00
Cornerstone planning group	-100.00
Eversource wealth advisors	-163.00
Raymond james financial	-200.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Mar 31, 2026	27	-70.65%	3,529,975	-97.47%	1	0.05%	12	-70.73%	7	-73.08%
Dec 31, 2025	24	-75.76%	20,150,499	-86.07%	7	0.26%	8	-82.98%	8	-68.00%
Sep 30, 2025	32	-66.32%	22,001,645	-86.74%	8	0.21%	8	-84.31%	14	-50.00%
Jun 30, 2025	93	-2.11%	165,894,039	9.60%	62	1.93%	49	25.64%	27	-15.63%
Mar 31, 2025	95	-12.04%	168,007,060	-0.18%	63	1.58%	39	-29.09%	32	6.67%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Syncona Ord	30.73M	11.55%	9.39M
Vanguard Health Care Inv	19.36M	7.27%	-
International Biotechnology Ord	7.82M	2.94%	-
FIAM Small Cap Core CIT Cl B	4.02M	1.51%	946.70K
AXA Framlington Health Fund - R Income	3.36M	1.26%	-
FIAM Small Cap Core Composite	3.14M	1.18%	-26.57K
Fidelity Small Cap Growth	2.57M	0.97%	-
US Small-Cap Growth II Equity Comp	2.02M	0.76%	-216.32K
Wellington Global Hlthcr Eq USD G Ac	1.79M	0.67%	-
Fidelity Stock Selector Small Cap	1.62M	0.61%	-348.11K

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-

AUTL Ownership FAQ

Who Owns Autolus Therapeutics?

Autolus Therapeutics shareholders are primarily institutional investors at 1.33%, followed by 18.08% insiders and 80.59% retail investors. The average institutional ownership in Autolus Therapeutics's industry, Biotech Stocks , is 33.91%, which Autolus Therapeutics falls below.

Who owns the most shares of Autolus Therapeutics?

Autolus Therapeutics’s largest shareholders are Mak capital one (33.62M shares, 12.63%), Blackstone (20.49M shares, 7.70%), and Syncona portfolio (16.64M shares, 6.25%). Together, they hold 26.58% of Autolus Therapeutics’s total shares outstanding.

Does Blackrock own Autolus Therapeutics?

Yes, BlackRock owns 2.00% of Autolus Therapeutics, totaling 4.44M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 15.44M$. In the last quarter, BlackRock increased its holdings by 380.18K shares, a 9.37% change.

Who is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested?

Syncona portfolio is Autolus Therapeutics’s biggest shareholder by percentage of total assets invested, with 89.33% of its assets in 16.64M Autolus Therapeutics shares, valued at 22.96M$.

Who is the top mutual fund holder of Autolus Therapeutics shares?

Syncona Ord is the top mutual fund holder of Autolus Therapeutics shares, with 11.55% of its total shares outstanding invested in 30.73M Autolus Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools